GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » RTW Biotech Opportunities Ltd (LSE:RTW) » Definitions » Net Change in Cash

RTW Biotech Opportunities (LSE:RTW) Net Change in Cash : $33.54 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is RTW Biotech Opportunities Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

RTW Biotech Opportunities's Net Change in Cash for the six months ended in Dec. 2023 was $-16.51 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was $33.54 Mil.

RTW Biotech Opportunities Net Change in Cash Historical Data

The historical data trend for RTW Biotech Opportunities's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RTW Biotech Opportunities Net Change in Cash Chart

RTW Biotech Opportunities Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial 43.77 -19.21 -5.78 10.35 31.45

RTW Biotech Opportunities Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -11.14 6.96 3.39 50.05 -16.51

RTW Biotech Opportunities Net Change in Cash Calculation

RTW Biotech Opportunities's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=33.541+0+-2.093+0
=31.45

RTW Biotech Opportunities's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-16.514+0+0+0
=-16.51

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $33.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RTW Biotech Opportunities Net Change in Cash Related Terms

Thank you for viewing the detailed overview of RTW Biotech Opportunities's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

RTW Biotech Opportunities Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » RTW Biotech Opportunities Ltd (LSE:RTW) » Definitions » Net Change in Cash
Comparable Companies
LSE:NAVF LSE:MWY LSE:ORIT LSE:HINT LSE:TPOU LSE:DIG LSE:ANII LSE:BIPS LSE:NESF LSE:FAS BLK BX KKR TSX:BAM OSTO:INVE A TSX:BN APO AMP LSE:III XSWX:PGHN
Traded in Other Exchanges
N/A
Address
St Julian’s Avenue, Royal Chambers, 1st Floor, Saint Peter Port, GGY, GY1 3JX
Website
https://www.rtwfunds.com/rtw-biotech-opportunities
RTW Biotech Opportunities Ltd is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. Its approach is driven by applying deep scientific expertise with a long-term investment horizon.

RTW Biotech Opportunities Headlines

No Headlines